BridgeMD
New treatment option for Sudden Cardiac Arrest
Official title FEMART-1 Pilot Study
ClinicalTrials.gov ID: NCT07596446
What this study is testing
- What it's testing
- The FEMART-1 Pilot Study is focused on evaluating the feasibility, safety, and procedural timing of prehospital femoral arterial sheath placement in patients with non-traumatic out-of-hospital cardiac arrest (OHCA), both during ongoing cardiopulmonary resuscitation and after return of spontaneous circulation (ROSC). The primary objective of the study is to enable invasive arterial blood pressure monitoring for targeted and continuous hemodynamic management using vasopressor therapy in the prehospital setting.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- \ Non-traumatic out-of-hospital cardiac arrest (OHCA). Patients meeting criteria for one of the following clinical scenarios: Group A - ECPR-like...
- Refractory cardiac arrest, including cardiac arrest occurring in the presence of the EMS crew.
- Age 18-70 years.
- Effective bystander cardiopulmonary resuscitation.
- Initial rhythm of ventricular fibrillation (VF), pulseless ventricular tachycardia (pVT), or pulseless electrical activity (PEA). Group B - post-ROSC...
You likely can't join if
- Trauma as the probable primary cause of cardiac arrest.
- Known severe comorbidity, including:
- terminal stage of incurable disease (advanced malignancy, advanced dementia, terminal pulmonary disease, terminal heart failure, or palliative care...
- established do-not-resuscitate (DNR) status,
- severe pre-existing neurological disability (CPC 3 or CPC 4),
- known severe peripheral arterial disease or known occlusion of lower limb arteries,
See the full eligibility criteria
- \ Non-traumatic out-of-hospital cardiac arrest (OHCA). Patients meeting criteria for one of the following clinical scenarios: Group A - ECPR-like group:
- Refractory cardiac arrest, including cardiac arrest occurring in the presence of the EMS crew.
- Age 18-70 years.
- Effective bystander cardiopulmonary resuscitation.
- Initial rhythm of ventricular fibrillation (VF), pulseless ventricular tachycardia (pVT), or pulseless electrical activity (PEA). Group B - post-ROSC group:
- Return of spontaneous circulation (ROSC) after non-traumatic OHCA.
- Age 18-70 years.
- Trauma as the probable primary cause of cardiac arrest.
- Known severe comorbidity, including:
- terminal stage of incurable disease (advanced malignancy, advanced dementia, terminal pulmonary disease, terminal heart failure, or palliative care status),
- established do-not-resuscitate (DNR) status,
- severe pre-existing neurological disability (CPC 3 or CPC 4),
- known severe peripheral arterial disease or known occlusion of lower limb arteries,
- suspected pulmonary embolism with indication for thrombolytic therapy,
- known severe hematological disease associated with severe thrombocytopenia,
- morbid obesity.
- Known or suspected pregnancy.
The study team makes the final eligibility decision.
Where it's taking place
- Prague, Czechia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Prague, Czechia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.